Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH||1F038A / 2||- / OT|
Administered by: Other Purchased by: ??
Symptoms: Pulmonary embolism
Life Threatening? No
Birth Defect? No
Permanent Disability? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days:
Write-up: Embolism pulmonary; This is a spontaneous report from a contactable physician downloaded from the regulatory authority. WEB, regulatory authority number FR-AFSSAPS-BX20218627. A 27-years-old female patient received second dose of BNT162B2 (COMIRNATY), intramuscular on 06Sep2021 (Batch/Lot Number: 1F038A) as single dose for covid-19 immunisation. Medical history included obesity. She had no medical history of Covid. The patient''s concomitant medications were not reported. The patient previously received first dose of BNT162B2 (COMIRNATY) on 06Aug2021 (lot Number: FE8244) as single dose for covid-19 immunisation and no information on the tolerance of dose 1. On day 1 from dose 2 on 07Sep2021, the patient experienced embolism pulmonary. The outcome of the event was recovered with sequel. The event was serious due to hospitalization. No follow-up attempts are possible. No further information is expected.
Copyright © 2022 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166